Drug Screening Market Competitive Landscape
Key players operating in the global drug screening market
include Thermo Fisher Scientific, Quest Diagnostics, Omega Laboratories, Abbott
Laboratories, Danaher Corporation, Express Diagnostics International Inc.,
Siemens Healthineers, Alfa Scientific Designs, F. Hoffmann La Roche, SureHire,
and OraSure.
Drug
screening involves testing of the samples such as urine, breath, oral fluid,
hair, and others for presence of any substances over the limit. The
significance of the drug screening is that a person under influence of the
drugs or alcohol is liable for road accidents, and other workplace issues.
Manufacturers
such as Abbott Laboratories provide drug screening tests for testing purposes
at workplace, in government organizations, rehabilitation centers, and other
places. These tests are painless and non-invasive. Moreover, manufacturers such
as Alere, Inc. (part of Abbott Laboratories) provide point-of-care diagnostic
tests for drug screening. Furthermore, drug addict individuals involved in
certain professions such as an air traffic controller, and commercial drivers
can risk safety of others, which can be avoided by pre-employment urine
testing. On-the-job accidents could also be reduced with the help of drug
screening. A urine drug test is painless and analyzes presence of prescription
drugs such as amphetamines, methamphetamines, benzodiazepines, marijuana,
barbiturates, cocaine, methadone, and opioids (narcotics).
Drug Screening Market Drivers
Competition
among leading manufacturers in the drug screening market is supporting the
growth of the drug screening market. Manufacturers are engaged in developing
innovative products in wide categories in order to maintain leading position in
the market. Alere, Inc. along with its partner company GenPrime, Inc., launched
point of care testing device, the xReader for work-place drug testing in 2016.
In 2017, Alere, Inc. launched Alere iCup Rx drug screen for detecting commonly
misused and abused prescription drugs. Moreover, technological advancements are
expected to boost growth of the drug screening market over the forecast period.
For instance, Intelligent Fingerprinting Limited launched non-invasive portable
fingerprint drug test in 2017.
Request a sample to stay abreast
on the key trends impacting this market: https://www.coherentmarketinsights.com/insight/request-sample/1696
Drug Screening Market Insights
North
America and Europe are expected to dominate the drug screening market over the
forecast period due to presence of leading manufacturers such as Alere, Inc.
Mergers and acquisitions by key players are expected to foster growth of the market
such as Abbott Laboratories acquisition of Alere, Inc. in 2017. Asia Pacific
region is expected to witness significant growth over the forecast period,
owing to increasing presence of leading manufacturers in the region.
Drug Screening Market Taxonomy-
The
global drug screening market is segmented on the basis of product type,
application, end user, and region.
By Product Type:
·
Instruments
o
Immunoassay analyzers
o
Chromatography Instruments
o
Breathalyzers
o
Drug testing Cups
o
Dip Cards
o
Oral Fluid Testing Products
·
Consumables
By Application:
·
Urine Testing
·
Breath Testing
·
Oral Fluid Testing
·
Hair Testing
·
Others
About Coherent Market Insights:
Coherent Market Insights is
a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
No comments:
Post a Comment